Enable Medicine

Menlo Park, United States

Enable medicine is a biotechnology company that develops biological cartography tools to generate cellular maps that help in drug discovery.

$60.0M raised

Apr 2022

Series A

Biotechnology Health Care Medical

Top Investors

General Catalyst Presight Capital Initialized Capital Anthos Capital Breyer Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Enable Medicine

How much funding has Enable Medicine raised?

Enable Medicine has raised $60.0M in total funding. The most recent round was Series A. The last funding was announced in April 2022.

Who are Enable Medicine's investors?

Enable Medicine's investors include General Catalyst, Presight Capital, Initialized Capital, Anthos Capital, Breyer Capital.

Where is Enable Medicine headquartered?

Enable Medicine is headquartered in Menlo Park, United States.

What does Enable Medicine do?

Enable medicine is a biotechnology company that develops biological cartography tools to generate cellular maps that help in drug discovery.

What stage is Enable Medicine at?

Enable Medicine is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 7, 2022.

MLA

"Enable Medicine — Funding & Investors." VCBacked, April 7, 2022, https://www.vcbacked.co/company/enable-medicine. Accessed July 2, 2026.

APA

VCBacked. (2022). Enable Medicine — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/enable-medicine

Wikipedia (cite web)

{{cite web |title=Enable Medicine — Funding & Investors |url=https://www.vcbacked.co/company/enable-medicine |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 7, 2022.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K